Literature DB >> 14708714

Hide-and-seek in the brain: a role for HLA-G mediating immune privilege for glioma cells.

Heinz Wiendl1, Meike Mitsdoerffer, Michael Weller.   

Abstract

This review summarizes the current knowledge on the expression and functional role of HLA-G in normal CNS cells and brain tumor cells in vitro and in vivo. The CNS has classically been viewed as an immune-privileged organ. Here we discuss some of the particularities of anti-tumoral responses within this compartment. Special emphasis is dedicated to the possible role of the non-classical MHC molecule HLA-G as an alternative mechanism of immune escape. We review the mechanisms how glioma cell-derived HLA-G may paralyze the immune system and which cellular subsets of the immune system are affected. Possible therapeutic implications derived from these observations include the targeting of HLA-G expression within the framework of inducing glioma-specific immunity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14708714     DOI: 10.1016/s1044-579x(03)00025-7

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  16 in total

Review 1.  Janus head: the dual role of HLA-G in CNS immunity.

Authors:  Yu-Hwa Huang; Laura Airas; Nicholas Schwab; Heinz Wiendl
Journal:  Cell Mol Life Sci       Date:  2010-11-18       Impact factor: 9.261

2.  Modulation of HLA-G expression in human neural cells after neurotropic viral infections.

Authors:  Monique Lafon; Christophe Prehaud; Françoise Megret; Mireille Lafage; Gaël Mouillot; Michèle Roa; Philippe Moreau; Nathalie Rouas-Freiss; Edgardo D Carosella
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Static image analysis as new approach for the characterization of tumor cell lysate used in dendritic cell vaccine preparation.

Authors:  Isabelle Müller; Dorothee Hartmann; Joachim Oertel; Cornelia M Keck; Hermann Eichler
Journal:  Transfus Med Hemother       Date:  2015-01-29       Impact factor: 3.747

Review 4.  [Brain tumors and epilepsy].

Authors:  H Stefan; I Blümcke; M Buchfelder
Journal:  Nervenarzt       Date:  2005-10       Impact factor: 1.214

Review 5.  Medulloblasoma: challenges for effective immunotherapy.

Authors:  Adam M Sonabend; Alfred T Ogden; Lisa M Maier; David E Anderson; Peter Canoll; Jeffrey N Bruce; Richard C E Anderson
Journal:  J Neurooncol       Date:  2011-12-16       Impact factor: 4.130

Review 6.  Tumour vaccine approaches for CNS malignancies: progress to date.

Authors:  Johnathan D Ebben; Brandon G Rocque; John S Kuo
Journal:  Drugs       Date:  2009       Impact factor: 9.546

7.  Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2'-deoxycytidine and interferon-γ treatments: results from a multicentric study.

Authors:  Isabela J Wastowski; Renata T Simões; Layale Yaghi; Eduardo A Donadi; João T Pancoto; Isabelle Poras; Emmanuèle Lechapt-Zalcman; Myriam Bernaudin; Samuel Valable; Carlos G Carlotti; Sébastien Flajollet; Stine S Jensen; Soldano Ferrone; Edgardo D Carosella; Bjarne W Kristensen; Philippe Moreau
Journal:  Am J Pathol       Date:  2012-12-04       Impact factor: 4.307

Review 8.  Current immunotherapeutic strategies for central nervous system tumors.

Authors:  Medina C Kushen; Adam M Sonabend; Maciej S Lesniak
Journal:  Surg Oncol Clin N Am       Date:  2007-10       Impact factor: 3.495

Review 9.  Clinical and biological significance of HLA-G expression in ovarian cancer.

Authors:  Jim Jinn-Chyuan Sheu; Ie-Ming Shih
Journal:  Semin Cancer Biol       Date:  2007-07-03       Impact factor: 15.707

10.  Genetic epidemiology of glioblastoma multiforme: confirmatory and new findings from analyses of human leukocyte antigen alleles and motifs.

Authors:  Wei Song; Avima M Ruder; Liangyuan Hu; Yufeng Li; Rong Ni; Wenshuo Shao; Richard A Kaslow; MaryAnn Butler; Jianming Tang
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.